首页> The oncologist> De-escalating first-line treatment in stage IVB or recurrent cervical cancer: outcomes of immunotherapy alone and systemic review.

De-escalating first-line treatment in stage IVB or recurrent cervical cancer: outcomes of immunotherapy alone and systemic review.

导出 LinkOut

翻译打印收藏纠错

第一作者： Akram,Saad

第一单位： Faculty of Medicine, Tel Aviv University, P.O.B 39040 Ramat Aviv, Tel Aviv 69978, Israel.;Sheba Cancer Center and Institute of Oncology, Tel-Hashomer, Derech Sheba 2, Ramat Gan, Israel.

作者： Akram,Saad ^[1] ; Alexandra,Taylor ^[2] ; Shira,Felder ^[1] ; Limor,Helpman ^[3] ; Smadar,Bauer ^[1] ; Ronnie,Shapira ^[1] ; Keren,Levanon ^[1] ; Jacob,Korach ^[3] ; Ronza,Atamneh ^[4] ; Samantha,Breslauer ^[5] ; Jeffrey,Goldstein ^[6] ; Shira,Peleg Hasson ^[7]

作者单位： Faculty of Medicine, Tel Aviv University, P.O.B 39040 Ramat Aviv, Tel Aviv 69978, Israel.;Sheba Cancer Center and Institute of Oncology, Tel-Hashomer, Derech Sheba 2, Ramat Gan, Israel. ^[1] The Royal Marsden, Department of Clinical Oncology, 203 Fulham Rd., London SW3 6JJ, United Kingdom. ^[2] Faculty of Medicine, Tel Aviv University, P.O.B 39040 Ramat Aviv, Tel Aviv 69978, Israel.;Gynecologic Oncology, Sheba Medical Center, Tel-Hashomer, Derech Sheba 2, Ramat Gan, Israel. ^[3] Faculty of Medicine, Tel Aviv University, P.O.B 39040 Ramat Aviv, Tel Aviv 69978, Israel. ^[4] Rappaport Faculty of Medicine, Technion Israel Institute of Technology, 1 Efron St. Bat Galim, Haifa 3525433, Israel. ^[5] Tel Aviv Sourasky Medical Center, Department of Radiation Oncology, Weizmann St 6, Tel Aviv-Yafo, Israel. ^[6] Faculty of Medicine, Tel Aviv University, P.O.B 39040 Ramat Aviv, Tel Aviv 69978, Israel.;Tel Aviv Sourasky Medical Center, Department of Medical Oncology, Weizmann St 6, Tel Aviv-Yafo, Israel. ^[7]

关键词 cervical cancer immunotherapy metastatic radiation stage-IVB survival